Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma

Umberto Falcone, MD PhD, Shaheena Bashir, Khalil Al-Farsi, MD, Laurie Watkins, C. Denise Turvey, RN, Norman Franke, MD, Armand Keating, MD, Michael Crump, MD, John Kuruvilla, MD

Blood (2015) 126 (23): 1995.

https://doi.org/10.1182/blood.V126.23.1995.1995

Published: 2015

Journal Articles

Early Relapse After Single ASCT For MM Patients Is a Major Predictor Of Survival In The Era Of Novel Agents

Victor H Jimenez Zepeda, MD, Suzanne Trudel, MD, MSC, FRCPC, Donna E. Reece, MD, Christine I. Chen, MD, Rodger E. Tiedemann, MD PhD FRACP FRCPA, Norman Franke, MD, Andrew Winter, Sr., RN, Vishal Kukreti, MD, FRCPC

Blood (2013) 122 (21): 3396.

https://doi.org/10.1182/blood.V122.21.3396.3396

Published: 2013

Journal Articles

Absolute Lymphocyte Count At Day+15 and +30 Post-ASCT As Predictors of Early and 1-Year Mortality for Patients with AL Amyloidosis Treated with a Single Autologous Stem Cell Transplant

Victor Hugo Jimenez-Zepeda, MD PD, Donna Reece, Suzanne Trudel, MD, MSC, FRCPC, Christine I. Chen, MD, Norman Franke, MD, Andrew Winter, Sr., RN, Rodger E. Tiedemann, MD PhD FRACP FRCPA, Vishal Kukreti, MD

Blood (2012) 120 (21): 4518.

https://doi.org/10.1182/blood.V120.21.4518.4518

Published: 2012

Journal Articles

Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival

Victor Hugo Jimenez-Zepeda, MD, Norman Franke, MD, Andrew Winter, Sr., RN, Suzanne Trudel, MD, MSC, FRCPC, Christine I. Chen, MD, Rodger E. Tiedemann, MD, PhD FRACP FRCPA, Vishal Kukreti, MD

Blood (2012) 120 (21): 595.

https://doi.org/10.1182/blood.V120.21.595.595

Published: 2012

Journal Articles

Very Good Partial Response and Complete Response Predict Superior Overall Survival and Progression Free Survival After Single Autologous Stem Cell Transplant in Patients with Multiple Myeloma,

Victor H Jimenez-Zepeda, MD, PD, Donna E. Reece, MD, FRCPC, Suzanne Trudel, MD, MSC, FRCPC, Christine Chen, MD, Andrew Winter, Sr., RN, Norman Franke, MD, Rodger E. Tiedemann, MD PhD FRACP FRCPA, Vishal Kukreti, MD, FRCPC

Blood (2011) 118 (21): 4111.

https://doi.org/10.1182/blood.V118.21.4111.4111

Published: 2011

Journal Articles

Absolute Lymphocyte Count As Predictor of Overall Survival for Patients with Multiple Myeloma Treated with Single Autologous Stem Cell Transplant: Experience of a Single Centre,

Victor H Jimenez-Zepeda, MD, PD, Donna E. Reece, MD, FRCPC, Suzanne Trudel, MD, MSC, FRCPC, Christine Chen, MD, Norman Franke, MD, Andrew Winter, Sr., RN, Rodger E. Tiedemann, MD PhD FRACP FRCPA, Vishal Kukreti, MD, FRCPC

Blood (2011) 118 (21): 4121.

https://doi.org/10.1182/blood.V118.21.4121.4121

Published: 2011

Journal Articles

Light Chain Deposition Disease: Impact of Stem Cell Tranplant on Hematological Response Achievement.

Victor H Jimenez-Zepeda, MD, PD, Norman Franke, MD, Andrew Winter, Donna E. Reece, MD, Suzanne Trudel, MD, MSC, FRCPC, Christine Chen, MD, Ahmed M. Rabea, MD, Vishal Kukreti, MD, FRCPC

Blood (2010) 116 (21): 4600.

https://doi.org/10.1182/blood.V116.21.4600.4600

Published: 2010

Journal Articles

High-Dose Melphalan for AL Amyloidosis: The Importance of Case Selection to Improve Clinical Outcomes

Victor H Jimenez-Zepeda, MD, PD, Norman Franke, MD, Diego Delgado, Andrew Winter, Keith Stewart, MBA, MB, CHB, Joseph R. Mikhael, MD, Donna E. Reece, MD, Suzanne Trudel, MD, MSC, FRCPC, Christine Chen, MD, Vishal Kukreti, MD, FRCPC

Blood (2010) 116 (21): 2403.

https://doi.org/10.1182/blood.V116.21.2403.2403

Published: 2010

Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma.

Joseph R. Mikhael, MD, Sahar Zadeh, A. Keith Stewart, MD, Christine Chen, MD, Suzanne Trudel, MD, Vishal Kukreti, MD, FRCPC, Andrew Winter, BScN, Norman Franke, Donna E. Reece, MD

Blood (2009) 114 (22): 1217.

https://doi.org/10.1182/blood.V114.22.1217.1217

Published: 2009

Journal Articles

Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation.

Luciano Wannesson, Lisa Wang, John Kuruvilla, Tracy Nagy, Ronnie Saragosa, Norman Franke, Armand Keating, Michael Crump

Blood (2009) 114 (22): 3226.

https://doi.org/10.1182/blood.V114.22.3226.3226

Published: 2009

Journal Articles

Predictors of Mortality in Patients Undergoing Autologous Stem Cell Transplant (ASCT) Admitted to the Intensive Care Unit: An Institutional Review of 1013 Transplant Patients over Five Years.

Martina A. Trinkaus, MD, Stephen E. Lapinsky, M.D., David C. Hallett, M.Sc, Norman Franke, M.D., Andrew Winter, B.ScN, Michael Crump, M.D., Donna E. Reece, M.D., Christine Chen, M.D., Suzanne Trudel, M.D., Ian Quirt, M.D., Armand Keating, M.D., Joseph R. Mikhael, M.D.

Blood (2007) 110 (11): 2876.

https://doi.org/10.1182/blood.V110.11.2876.2876

Published: 2007

Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer Disease Free Interval after First ASCT.

Joseph R. Mikhael, MD, Sahar Zadeh, BSc, Sara Samiee, MD, Keith Stewart, MD, Christine Chen, MD, Suzanne Trudel, MD, Vishal Kukreti, MD, Norman Franke, MD, Andrew Winter, BScN, Drew Phillips, Donna Reece, MD

Blood (2007) 110 (11): 946.

https://doi.org/10.1182/blood.V110.11.946.946

Published: 2007

Journal Articles

Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients with Dialysis-Dependent Renal Failure Is Effective but Carries High Rates of Toxicity.

Lisa Chodirker, MD, Joseph R. Mikhael, M.Ed, MD, Keith Stewart, MD, Andrew Winter, BScN, Donna E. Reece, MD, Norman Franke, MD, Suzanne Trudel, MD, Vishal Kukreti, M.Sc, MD, Wei Xu, PhD, Christine I. Chen, M.Ed, MD

Blood (2007) 110 (11): 954.

https://doi.org/10.1182/blood.V110.11.954.954

Published: 2007

Journal Articles

Outcome after Second Autologous Stem Cell Transplantation as Salvage Therapy in Patients with Relapsed Multiple Myeloma.

Joseph R. Mikhael, MD, Sara Samiee, MD, A. Keith Stewart, MD, Christine Chen, MD, Suzanne Trudel, MD, Norman Franke, MD, Andrew Winter, BScN, Hong Chang, MD, PhD, Donna E. Reece, MD

Blood (2004) 104 (11): 943.

https://doi.org/10.1182/blood.V104.11.943.943

Published: 2004

NARROW

Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma

Early Relapse After Single ASCT For MM Patients Is a Major Predictor Of Survival In The Era Of Novel Agents

Absolute Lymphocyte Count At Day+15 and +30 Post-ASCT As Predictors of Early and 1-Year Mortality for Patients with AL Amyloidosis Treated with a Single Autologous Stem Cell Transplant

Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival

Very Good Partial Response and Complete Response Predict Superior Overall Survival and Progression Free Survival After Single Autologous Stem Cell Transplant in Patients with Multiple Myeloma,

Absolute Lymphocyte Count As Predictor of Overall Survival for Patients with Multiple Myeloma Treated with Single Autologous Stem Cell Transplant: Experience of a Single Centre,

Light Chain Deposition Disease: Impact of Stem Cell Tranplant on Hematological Response Achievement.

High-Dose Melphalan for AL Amyloidosis: The Importance of Case Selection to Improve Clinical Outcomes

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma.

Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation.

Predictors of Mortality in Patients Undergoing Autologous Stem Cell Transplant (ASCT) Admitted to the Intensive Care Unit: An Institutional Review of 1013 Transplant Patients over Five Years.

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer Disease Free Interval after First ASCT.

Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients with Dialysis-Dependent Renal Failure Is Effective but Carries High Rates of Toxicity.

Outcome after Second Autologous Stem Cell Transplantation as Salvage Therapy in Patients with Relapsed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only